Sara Giraudi

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.

Journal: Breast (Edinburgh, Scotland)
Published: March 20, 2017

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.

Journal: Oncotarget
Published: November 30, 2016

The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.

The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.

Journal: BMC cancer
Published: September 22, 2016

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 29, 2016

Treatment with aromatase inhibitors and markers of cardiovascular disease.

Treatment with aromatase inhibitors and markers of cardiovascular disease.

Journal: Breast cancer research and treatment
Published: July 24, 2016

Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.

Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.

Journal: JAMA
Published: January 01, 2016

Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.

Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.

Journal: Tumori
Published: March 26, 2015

Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer.

Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer.

Journal: Anticancer research
Published: July 02, 2014

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.

Journal: Cancer treatment reviews
Published: October 10, 2013

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole.

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole.

Journal: British journal of cancer
Published: September 05, 2013

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients.

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients.

Journal: Expert review of anticancer therapy
Published: October 18, 2012

Stevens-Johnson syndrome after treatment with bendamustine.

Stevens-Johnson syndrome after treatment with bendamustine.

Journal: Leukemia research
Published: March 07, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026